Related Experiment Videos
Delivering novel targets and antibiotics from genomics
D J Payne1, D J Holmes, M Rosenberg
1Antimicrobials and Host Defense (UPI 345), GlaxoSmithKline, Collegeville, PA 19426-0989, USA. David_J_Payne@sbphrd.com
Current Opinion in Investigational Drugs (London, England : 2000)
|March 15, 2002
Summary
Advances in DNA sequencing and bioinformatics enable the discovery of new antibacterial targets. These tools help evaluate potential drug targets for spectrum and selectivity against pathogenic bacteria.
Area of Science:
- Genomics
- Bioinformatics
- Microbiology
Background:
- DNA sequencing technology advances allow whole genome analysis of pathogenic bacteria.
- Bioinformatic tools facilitate comparative genomic studies.
- Gene-essentiality technologies identify novel bacterial genes critical for growth and pathogenicity.
Purpose of the Study:
- To review how recent technological advancements impact the discovery and characterization of antibacterial targets.
- To highlight the use of specific examples from diverse bacterial processes.
Main Methods:
- Comparative genomic analysis using advanced sequencing data.
- Application of gene-essentiality screening in pathogenic organisms.
- Bioinformatic evaluation of potential antibacterial targets for spectrum and selectivity.
Main Results:
- Increased ability to consider limitations and advantages of antibacterial targets.
- Unprecedented rate of uncovering essential genes and critical gene products.
- Facilitation of discovery for both known and novel antibacterial targets.
Conclusions:
- Technological progress in genomics and bioinformatics is revolutionizing antibacterial target discovery.
- These advancements are crucial for developing new strategies against bacterial infections.
- The review provides insights into diverse bacterial processes for target identification.